Physician profile
Gregory Pellizzon
NPI 1932190345
$1,837.25
in general payments reported to CMS, 2019-2025
27 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $52.90 · 2021: $95.36 · 2022: $53.41 · 2023: $191 · 2024: $746 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $284.88 | 2023-2025 | |
| Boston Scientific Corporation | $209.22 | 2022-2025 | Varithena Administration Pack, Watchman Access System |
| Philips North America LLC | $152.05 | 2023-2025 | (5044) Mcot, (5050) Extended Holter, Extended Holter |
| Novo Nordisk INC | $122.77 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Baxter Healthcare | $113.29 | 2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $111.77 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $110.64 | 2024-2025 | Camzyos |
| Medicomp INC | $73.35 | 2024 | Telepatch Cardiac Monitor |
| Pfizer INC. | $64.10 | 2025 | |
| Biotronik INC. | $61.18 | 2019 | |
| Irhythm Technologies, INC. | $55.94 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.09 | 2021-2024 | Lifevest |
| Medtronic, INC. | $44.85 | 2022-2024 | Closurefast |
| Astrazeneca Pharmaceuticals Lp | $44.29 | 2019-2025 | Lokelma |
| Scpharmaceuticals INC. | $42.44 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $41.65 | 2021-2024 | Assurity |
| Shockwave Medical, INC | $39.15 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.01 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $33.63 | 2023 | Verquvo |
| Bard Peripheral Vascular, INC. | $32.26 | 2024 | Venclose Maven Catheter |
| Heartflow, INC. | $19.53 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.11 | 2025 | Jardiance |
| Chiesi USA, INC. | $17.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.36 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $16.02 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.55 | 2024 | Onpattro |
| Glaxosmithkline, LLC. | $14.35 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Pellizzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.